Quick Answer
GoodRx Holdings, Inc. reported Diluted EPS of $0.09 per share for fiscal year 2025.
GoodRx Holdings, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.09 | +125.0% |
| 2024 | $0.04 | +300.0% |
| 2023 | -$0.02 | +75.0% |
| 2022 | -$0.08 | -33.3% |
| 2021 | -$0.06 | +94.4% |
| 2020 | -$1.07 | -694.4% |
| 2019 | $0.18 | +50.0% |
| 2018 | $0.12 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | -100.0% | -100.0% |
| June 30, 2025 | $0.04 | +100.0% | +33.3% |
| March 31, 2025 | $0.03 | — | +200.0% |
| September 30, 2024 | $0.01 | +111.1% | -50.0% |
| June 30, 2024 | $0.02 | -85.7% | — |
| March 31, 2024 | $0.00 | +100.0% | +100.0% |
| September 30, 2023 | -$0.09 | +10.0% | -164.3% |
| June 30, 2023 | $0.14 | — | +1500.0% |
- GoodRx Holdings, Inc. showed an increase of +125.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, GoodRx Holdings, Inc.’s diluted eps has declined by 25.0% (from $0.12 per share to $0.09 per share).
- The most recent figure is from GoodRx Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: